Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

For fiscal 2024, analysts expect PFE to report an EPS of $2.66, up 44.6% from $1.84 in fiscal 2023 . Shares of PFE have gained 3% on a YTD basis, significantly underperforming both the S&P 500 Index's ...

The stock's rise snapped a three-day losing streak.

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

As we move further into October, many investors may be looking to identify certain stocks with the potential to provide ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

W hat a twist! An activist investment fund, Starboard Value, has recently been pushing Pfizer (NYSE: PFE) to increase ...

In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...